AccessibilityHelpAbout Us
Meihua International Medical Technologies logo

Meihua International Medical Technologies(NASDAQ) MHUA

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-99%
5 YearN/A
1 Year-83%
1 Month-8%
N/A
Meihua International Medical Technologies last closing stock price
MetricPriceDate
Last closeUSD 7.002026-09-10
Meihua International Medical Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 7.002026-09-03
1 month-8.26%USD 7.632026-08-11
3 month-15.66%USD 8.302026-06-12
Year to date+241.46%USD 2.052025-12-31
1 year-83.01%USD 41.202025-09-10
3 year-97.08%USD 240.012023-09-11
Since inception-99.46%USD 1,292.002022-02-16

Meihua International Medical Technologies Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$183.80M

Net Income (TTM)

$18.55M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Sep 18, 2025

MHUA News

surgery robotic surgery patient in hospital

Why Shares of Meihua International Soared This Week

James HalleyFeb 17, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Meihua International Medical Technologies

Meihua International Medical Technologies Co., Ltd. is a Chinese enterprise focused on the production and commercialization of medical consumables. Established in 1991, the company offers a diverse range of single-use medical devices and serves a global customer base.

Products and Services
  • Single-use medical devices across Class I, II, and III
  • Non-bottled items like brushes and patient identification bracelets
  • Polyethylene bottled solutions, including containers for eye drops
Growth Outlook
  • Revenue of $37.98 million in Q2 2025, showing strong demand
  • Net income of $3.15 million in Q2 2025, indicating profitability
  • Global export presence across multiple continents enhances market reach
Financial Highlights
  • Gross profit margin of 33.21% in Q2 2025, reflecting operational efficiency
  • Current ratio of 8.42, indicating strong liquidity position
  • Net income of $6.13 million in Q4 2024, showcasing consistent profitability
Meihua International Medical Technologies operates in the medical instruments and supplies industry, providing essential products to healthcare institutions. The company has demonstrated a solid financial performance, with a notable gross profit margin and a strong liquidity position, which are critical for sustaining operations and growth. The recent quarterly results indicate a positive trend in revenue and net income, suggesting that the company is well-positioned to capitalize on the growing demand for medical consumables. With a diverse product portfolio and a global distribution network, Meihua International Medical Technologies presents a compelling opportunity for potential investors interested in the healthcare sector.
AI Generated • Aug 30, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

486

CEO

Leyi Lee

Website

www.meihuamed.com

Headquarters

Yangzhou, 225000, CN

MHUA Financials

Key Financial Metrics (TTM)

Gross Margin

30.88%

Operating Margin

13.41%

Net Income Margin

10.98%

Return on Equity

3.83%

Return on Capital

8.57%

Return on Assets

3.27%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$61.75M

Operating Income

$23.13M

EBITDA

$24.85M

Operating Cash Flow

$12.43M

Capital Expenditure

-$324.57K

Free Cash Flow

$12.11M

Cash & ST Invst.

$15.55M

Total Debt

$11.45M

Meihua International Medical Technologies Performance Analysis

Meihua International Medical Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 103,346,341-0.7%
20232023-12-31USD 97,098,915-6.0%
20242024-12-31USD 96,909,642-0.2%
20252025-12-31USD 61,791,957-36.2%
Meihua International Medical Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-311.5%
Q22024-06-30-7.3%
Q42024-12-3113.7%
Q22025-06-30-26.3%
Meihua International Medical Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 26.67-70.0%
20232023-12-31USD 48.5682.1%
20242024-12-31USD 39.62-18.4%
20252025-12-31USD 18.04-54.5%
Meihua International Medical Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-36.5%
Q22024-06-30-19.4%
Q42024-12-3136.7%
Q22025-06-30-53.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$37.98M

-21.2%

Gross Profit

$12.61M

-26.2%

Gross Margin

33.21%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

619

N/A

Net Income

$3.15M

-55.5%

EBITDA

$3.51M

-63.1%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

$15.55M

-12.9%

Total Debt

$11.45M

+59.6%

Accounts Receivable

$117.67M

+20.8%

Inventory

$1.10M

-33.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$11.45M

+59.6%

Return on Assets

3.27%

N/A

Return on Invested Capital

4.38%

N/A

Free Cash Flow

-$9.91M

+0.9%

Operating Cash Flow

-$9.90M

-82.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LUCYLucyd, Inc
$0.84-0.98%
SSKNSTRATA Skin Sciences, Inc.
$0.01+0.00%
POAIPredictive Oncology Inc.
$4.91+6.28%
SBFMSunshine Biopharma, Inc.
$1.06-1.85%

Trending Stocks

Symbol / CompanyPricePrice Chg
KHCKraft Heinz
$24.60+0.01%
ACVAACV Auctions
$10.41+0.44%
TNONTenon Medical
$5.93+0.12%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$19.16+0.03%

Questions About MHUA

What is the current price of Meihua International Medical Technologies?

Meihua International Medical Technologies is trading at N/A per share.

What is the 52-week range for Meihua International Medical Technologies?

Over the past 52 weeks, Meihua International Medical Technologies has traded between N/A and N/A.

How much debt does Meihua International Medical Technologies have?

As of the most recent reporting period, Meihua International Medical Technologies reported total debt of $8.99M.

How much cash does Meihua International Medical Technologies have on hand?

Meihua International Medical Technologies reported $15.15M in cash and cash equivalents in its most recent financial results.

What is Meihua International Medical Technologies’s dividend yield?

Meihua International Medical Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services